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The antiviral activity of a surface-bonded quaternary 
ammonium chloride (QAC) was examined in this study. 
The mechanism of inactivation was elucidated by a 
combination of infectivity assay, radioactive labeling as- 
say, and sedimentation analysis. Although the virions 
are still infectious when attached onto the chemically 
modified surface, we found these viruses are inactivated 
if they are eluted from the surface. The inactivation is 
caused by the disruption of the viral envelope with sub- 
sequent release of the nucleocapsid. No evidence indi- 
cates the released nucleocapsid is further disrupted. An 
enveloped virus shows a much higher affinity for the 
QAC-treated surface than a nonenveloped one due to 
hydrophobic interaction. The QAC-treated beads can 
effectively remove the enveloped viruses at low pro- 
tein concentrations. The titer of herpes simplex virus 
was reduced by a factor of nearly 5 logarithm units in a 
0.5 wt YO bovine serum albumin solution with less that 
10% protein loss. However, the presence of proteins in 
the solution reduced both the rate and capacity of this 
nonspecific adsorption-inactivation process. As a con- 
sequence, the removal efficiency is relatively poor in so- 
lutions with high protein content. 
INTRODUCTION 
Quaternary ammonium chlorides (QAC) are cationic 
surface-active agents with antimicrobial activity. The 
major mode of action of QAC was identified as the 
cytolytic damage caused by its effects on cellular perme- 
a b i l i t ~ . ~  The virucidal capacity of a QAC-Zephiran 
(alkyl-dimethylbenzylammonium chloride) against various 
types of viruses was summarized by Klein and Defore~t .~  
They reported that Zephiran can effectively inactivate 
lipid-containing viruses like vaccinia virus, some nonlipid 
viruses such as reovirus, and bacteriophages but is not ef- 
fective against smaller nonlipid viruses such as picorna- 
viruses. QAC display their antimicrobial activity even after 
being covalently immobilized on inert supports because 
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they can act on the membranes of various cells. The ef- 
fects of surface-bonded organosilicon QAC on bacteria, 
yeast, fungi, and algaes have been the topic of several pa- 
pers .325,6-8 The antimicrobial activity of immobilized QAC 
is not due to leaching of the compound since the radio- 
tracer study by Isquith3 showed no leakage of the immobi- 
lized QAC from the surface. Our own cytotoxicity tests 
also confirmed this point. However, the antiviral activity 
of these immobilized compounds has not been investigated 
previously. 
In the current study, we have demonstrated the efficacy 
of QAC-treated surfaces to remove an enveloped virus, 
herpes simplex virus type-1 , in aqueous solutions with and 
without the presence of proteins. Experiments have further 
demonstrated that the viruses were inactivated. The 
mechanism that underlies this inactivation is elucidated by 
using doubled-labeled HSV- 1 .  
MATERIALS AND METHODS 
Chemicals 
3-(Trimethoxysilyl)propyldimethyloctadecyl ammonium 
chloride (Si-QAC), Dow Corning 5700 antimicrobial 
agent, was provided by W. Curtis White (Dow Corning, 
Midland, MI).  It is a methanolic solution containing 
42 wt % of this active ingredient. [Methyl-3H]thymidine 
(20 Ci/mmol), [methyl-I4C]thymidine (58 mCi/mmol), 
and [2-3H]mannose (25 Ci/mmol) were purchased from 
New England Nuclear (Boston, MA). Other chemicals 
were of reagent grade and were purchased from various 
commericial sources, 
Preparation of Adsorbent 
Dried alginate-magnetite beads (Fig. 1) were prepared 
by a method modified from that described by Bums et al. 
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Figure 1. Scanning electron micrograph of the QAC-treated beads 
with the following modifications .9 Barium chloride was 
used as a gel-inducing agent for better stability. I”  The 
beads were further stabilized by treating with glutaralde- 
hyde in the presence of polyethyleneimine to avoid disso- 
lution. ‘I  In brief, the alginate-magnetite gel spheres were 
suspended in 0.5% (w/v) polyethyleneimine-HC1 in 
50mM CaCl, (pH 7.0) for 24 h at room temperature with 
stirring. The gel spheres were washed briefly with H,O 
and subsequently incubated in 1% (v/v) glutaraldehyde, 
lOmM sodium phosphate (pH 7.0) at room temperature for 
1 min with stirring. To remove or “neutralize” the unre- 
acted glutaraldehyde molecules, the gel spheres were 
washed 3 times with H,O and incubated with 1M glycine 
(pH 7.0) for 30 min so that glutaraldehyde does not leach 
out from the beads. The treated preparation was washed in 
H,O and stored at 4°C until the drying step. Dried beads 
with diameters between 0.15 and 0.25 mm were obtained 
by crushing the original spherical beads. A 1% solution of 
Si-QAC was prepared by diluting the stock solution in dis- 
tilled water at pH 5 .  After the beads were added to the 
Si-QAC solution, the reaction temperature was raised to 
about 50°C for 10 min. The pH was adjusted to 10.5, and 
reaction continued for an additional 10 min. The beads 
were dried in an oven (lOO”C), rinsed several times with 
sterile deionized water (pH 7.0), and stored at 4°C. 
Cell Culture 
BSC-1 cells (an established line of African green mon- 
key kidney cells) were grown as a monolayer in minimal 
essential medium (MEM) with Earle’s salts supplemented 
with 10% fetal bovine serum (FBS) and 1.1 g/L sodium 
bicarbonate. Cells were passaged according to conven- 
tional procedures by using 0.05% trypsin plus 0.02% ethyl- 
enediaminetetraacetic acid (EDTA) in HEPES-buffered 
balanced saline (HBS). Tissue culture flasks were incu- 
bated at 37°C in a humidified 3% C0,-97% air atmo- 
sphere. Total cell counts were made using a Coulter 
counter equipped with a 100-pm orifice. 
Virus and Plaque Assay 
HSV-1 strain 148 was passaged in KB cells to prepare 
virus stocks of high titer (108-109 PFU/ml) as described 
pre~iously.’~ HSV-1 was assayed by using monolayer cul- 
tures of BSC-1 cells grown in six-well cluster dishes. The 
cells were planted 3 X lo5 cells/well in MEM(E) with 
10% FBS and 1.1 g/L sodium bicarbonate. After 24 h the 
cell sheet was about 80% confluent and was inoculated 
with 0.2 mL virus suspension to be assayed and incubated 
for 1 h to permit viral adsorption. The cells were then 
overlaid with 3 mL medium containing 0.5% methocel 
(4000 cP) (Dow Chemical Midland, MI) incubated for an- 
other 2 days. After aspiration of the overlay, the cells were 
fixed and stained with crystal violet in 20% methanol, and 
the macroscopic plaques were enumerated. 
Preparation of Labeled Virus 
HSV- 1 with [3H]-labeled DNA was prepared using 
[3H]thymidine by a method similar to the one described 
previously.14 Monolayers of KB cells in 150-cm2 tissue 
culture flasks were grown to 80% confluence and then in- 
fected with HSV-1 (multiplicity of infection, M.O.I. = 20) 
in virus growth medium [VGM, MEM(E) with 0.127 g/L 
L-arginine, buffered with 25mM HEPES, pH 7.4, at 22°C 
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and supplemented with 10% FBS]. Virus (M.O.I. = 0.1) 
was allowed to adsorb for 1 h at 37°C. Then each mono- 
layer was rinsed twice with warm VGM without serum 
to remove unadsorbed viruses. Thirty milliliters of VGM 
was added to each flask for an additional 2 h incubation. 
The [3H]thymidine was added to give a concentration of 
17 pCi/mL in each flask, and the incubation was continued 
for 36 h to permit maximum production of supernatant 
virus. The radioactive suspension was then briefly soni- 
cated and centrifuged at a low speed to remove cells and 
cell debris. The supernatant fluid was further centrifuged 
using a Beckman JA-21 rotor at 18,OOOg for 20 min at 4°C 
in a Beckman 5-21 preparative centrifuge to pellet mature 
virions. The virus was resuspended in a small volume of 
medium [MEM(E) with 5% FBS], then further purified by 
sedimentation through 5-25% sucrose with a 45% sucrose 
cushion in a SW 50.1 rotor at 150,OOOg for 1 h in a Beck- 
man L3-50 ultracentrifuge. The band of labeled virus was 
collected and dialyzed against HBS at 4°C. The virus was 
pelleted using a JA-21 rotor as described above and resus- 
pended in MEM(E) with 5% FBS. The final preparations 
were stored at -76°C until retrieved. The double-labeled 
([3H] and [I4C]) HSV-1 was prepared by the same proce- 
dure described above except that [methyl-14C]thymidine 
(10 pCi/mL) and [2-3H]mannose (7 pCi/mL) were used 
to label viral nucleocapsid and envelope, respectively. The 
[2-3H]mannose is commonly used as a specific viral enve- 
lope glycoprotein label as described by Eisenberg et al.” 
To facilitate the uptake of [2-3H]mannose by the cells, 
glucose-free Dulbecco’s modified Eagle’s medium with 
350 mg/L L-glutamine and 110 mg/L sodium pyruvate 
was used for the preparation of VGM. 
Protein Assay 
Samples collected in all experiments were cooled and 
stored at 4°C. The concentration of total protein in the SO- 
lution was assayed by the method of Bradford.16 
Batch Adsorption Experiments 
During these experiments, adsorbents and viruses were 
continuously mixed in vials by a tube rocker (30 cycles/s) 
at room temperature. To prevent virus adsorption onto vial 
walls, the vials were filled with 5% BSA in HBS for 30 
min and air dried after discarding the BSA solutions to 
coat the inner surfaces. Reaction mixtures of known com- 
position were made by adding the stock solution to HBS at 
pH 7.0. A solution of 0.5% BSA in HBS was used in all 
experiments unless otherwise stated. All stock chemical 
solutions were filter sterilized and stored at 4°C. 
In the equilibrium studies of virus adsorption, the time 
required to reach equilibrium was determined by periodi- 
cally sampling over a 24-h period. In the kinetic studies, 
samples were withdrawn at predetermined time intervals 
and assayed for virus titers. Each adsorption experiment 
was performed at least twice and the averaged results were 
presented. 
Mechanistic Study of Virus Inactivation 
The experimental scheme in Figure 2 was designed to 
elucidate the mechanism of HSV-1 inactivation on a QAC- 
treated surface. The [3H]-labeled HSV-I was used in this 
experiment. The “control vial” contained the virus suspen- 
sion without adsorbent while the “reaction vial” had 
10 wt % QAC-treated beads. Both vials were shaken gen- 
tly (30 cycles/s) at room temperature for 2 h. Then the 
first set of samples were collected from the supernatant of 
both vials and saved for the assays of infectivity and radio- 
activity. Sedimentation analysis also was carried out. Elu- 
tion was subsequently performed at room temperature for 1 
h by directly adding 4X strength eluant (1% tryptone, 10% 
FBS, and 1M glycine) to the suspension as described by 
Murray and Laband.” The second set of samples from 
both vials was collected and assays were performed ac- 
cordingly. Although little variation was observed in repli- 
cate experiments, values were obtained in two trials and 
represent the means of four determinations. 
Sedimentation Analysis of Labeled Virus 
Changes in the sedimentation profiles of the radioac- 
tively labeled HSV-I by the adsorption and elution steps 
were determined by rate-zonal centrifugation. l8 Virus sus- 
pension (0.4 mL) was layered onto a 5-45% sucrose gra- 
dient in HBS. Centrifugation was carried out using a SW 
50.1 swing-out rotor at 150,OOOg for 45 min at 4°C in a 
Beckman model L3-50 ultracentrifuge, and fractions col- 
lected from the bottom of the gradient were analyzed for 
total radioactivity in scintillation cocktail. Counts per min- 
ute were determined in a Beckman LS 8100-Texas In- 
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tivation using QAC-treated beads. 
Experimental scheme for the mechanistic study of virus inac- 
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struments 733 liquid scintillation spectrometer system. For 
samples with [3H] and [I4C] double labeling, standard cali- 
bration was run to subtract [“C] spillover radioactivity in 
[3H] counting window. 
RESULTS 
Effect of Protein Concentration on HSV-1 
Adsorption to QAC-Treated Beads 
Using the experimental procedure described above, we 
showed the QAC-treated beads were able remove HSV-1 
effectively even in the presence of 0.5% BSA by weight 
(Fig. 3). The virus titer, starting from 1.0 X lo7 PFU/mL, 
dropped down more than 1 log in the first 5 min, was fur- 
ther reduced to 2.0 X 10’ PFU/mL, then leveled off. The 
total titer reduction was close to 5 logs. On the other hand, 
the protein recovery was more than 90%. A parallel experi- 
ment using dried alginate-magnetite beads without QAC 
treatment showed that the titer reduction was only 8%. 
Hence, neither untreated beads nor thermal inactivation 
was the major cause of the observed 5-log titer reduction. 
In addition, the pH of adsorption medium (0.5% BSA in 
HBS) did not change throughout the experiment. As ex- 
pected, BSA molecules compete with the viruses for the 
surface-binding sites. The binding capacity of the QAC- 
treated beads was decreased with increased BSA concen- 
tration (Fig. 4). The titer reduction was close to 5 logs for 
0 and 0.5% BSA, 2 logs for 1% BSA, and only 1 log for 
4% BSA. Presumably the rate of BSA binding to the sur- 
face is higher as the concentration is increased. These re- 
sults suggest that the QAC-treated bead is a very effective 
virus adsorbent at low protein concentrations. However, 
the titer reduction at high protein concentrations is poor 
due to the competitive binding of protein molecules. 
0 
0 20 40 60 80 100 120 
Time (min) 
Figure 3. Effect of batch adsorption on HSV-I titer reduction and BSA recovery using 
QAC-treated beads. Samples from the supernatant were assayed for virus titer (0) and 
BSA concentration (+). The initial BSA concentration was 0.5%. 
Figure 4. Effect of BSA concentration on HSV-I titer reduction using QAC- 
treated bead. Control was the virus suspension containing no adsorbent. Batch ad- 
sorption experiments were camed out in solutions of various BSA concentrations for 
2 h at room temperature with 10% QAC-treated bead. 




Recovery of HSV-1 Infectivity and 
During Adsorption and Elution 
Data from sampling I and sampling I1 in Figure 2 were 
examined to compare the recovery of infectivity and radio- 
activity of the viruses in various stages of the experiment. 
Figure 5(a) shows the effects of adsorption and elution on 
the HSV-1 infectivity. The virus suspension was mixed 
with 10% by weight QAC-treated beads and gently shaken 
for 2 h at room temperature. The HSV-1 titer reduction 
was more than 4 logs. However, the elution experiments 
indicated that almost all the lost infectivity cannot be re- 
covered. For the same set of samples, the effects of ad- 
sorption and elution on HSV- 1 radioactivity are illustrated 
in Figure 5(b), which shows the results from samples of 
parallel experiments with 1 : 2 dilutions of initial virus titer. 
The radioactivity of the virus suspensions were consis- 
tently reduced by only 40% of the original value while the 
elution step recovered about half of the adsorbed radioac- 
tivity. In other words, the specific infectivity of virus in 
the suspensions was reduced drastically by the adsorption 
and elution steps. 
Effects of Adsorption and Elution on 
Sedimentation Behaviors of Virus Suspensions 
To elucidate the mechanism of enveloped virus inactiva- 
tion on QAC-treated surface, double-labeled HSV- 1 (with 
[3H] in the envelope only and [I4C] in the nucleocapsid 
only) was used in adsorption-elution experiments. The 
sedimentation behaviors of the viral particles were exam- 
ined by centrifugation through 5-45% sucrose gradient. 
Since it is a rate-zonal centrifugation, the resolution of par- 
ticles is based mainly on size difference. Figure 6(a) shows 
the sedimentation profiles, both [3H] and [“C], of the virus 
suspension in which no adsorbent was added (control). 
There are two peaks appearing in the [“C] profile of the 
control, whereas there is only one in the [3H] profile. No- 
tice that the first peak (from the bottom) of the [“C] pro- 
file coincides with the only peak in the [3H] profile. That 
is, evidently, the particles in the second peak of the [“C] 
profile do not contain [3H]-labeled viral particles. In addi- 
tion, based on the fact that bigger particles settle faster 
than smaller ones as well as the infectivity assay results of 
each fraction [Fig. 6(a), inset], we determined that the vi- 
ral particles in the first peak of the [“C] profile are infec- 
tious virions of HSV-1 (180 nm diameter) while the ones 
in the second peak are noninfectious nucleocapsids of 
HSV- 1 (105 nm diameter). The possible virus aggregates 
would stay in the leading region of the first peak (i.e., 
above 45% sucrose). Two points can be made by compar- 
ing the sedimentation profiles of the control [Fig. 6(a)] and 
that of the reaction [Fig. 6(b)]. First, the first peak of the 
[I4C] profile and the only peak of the [3H] profile were al- 
most totally eliminated. Second, the viral particles in the 
second peak of the [“C] profile were enriched. These re- 
sults suggest that nearly all the enveloped virus particles 
were adsorbed by the QAC-treated beads as indicated also 
Figure 5. Comparative recovery of HSV-1 (a) infectivity and (b) radioactivity in 
various stages of the mechanistic study. A, B, and C were samples of parallel experi- 
ments with 1 :2  dilution. The measurements of the control (N) that contains no adsor- 
bent was compared with those of samples after adsorption (8) and after elution ( 
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Figure 6. Effect of adsorption and elution on the sedimentation behaviors of double- 
labeled HSV-I particles. Samples were analyzed by sedimentation in gradients (5% to 45% 
sucrose, SW 50.1, 150,000 x g,  45 min, 4°C). The arrows show the direction of sedimen- 
tation. The [I4C] (+) and 13H] (El) profiles in (a) are the control containing no adsorbent; the 
corresponding virus titer (PFU/ml X 10’) in each fraction (A) is shown in the inset. The 
sedimentation profiles of viral particles from sample I (after adsorption) and sample I1 (after 
elution) in Fig. 2 are shown in (b) and (c), respectively. 
by the results of the infectivity assay [5-log titer reduction, 
as shown in Fig. 5(a)]. Furthermore, a portion of the [I4C] 
radioactivity carried by the viral DNA in the bulk solution 
can be attributed to the release of the nucleocapsids. The 
latter statement was proven by the elution experiment, 
are very low in all fractions of Figures 6(b) and (c). This 
suggests that the envelope membrane of HSV-1 was tightly 
adsorbed by the QAC-treated surface, which is highly 
hydrophobic. 
which demonstrated the eluted viral particles were appar- 
ently noninfectious nucleocapsids [Fig. 6(c)]. We also ana- 
lyzed the sedimentation profiles of the beads washed with 
Infectivity of HSV-1 Adsorbed on QAC-Treated 
Surface 
HBS before the elution step. It was found that the profiles 
were very similar to Figure 6(c) with only one peak in the 
[I4C] profile at around fraction 15. The [3H] radioactivities 
To investigate whether the virus particles were still 
infectious when they are adsorbed on the QAC-treated 
surface, we washed the beads taken out right after the 
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Figure 7. 
is caused by the disruption of the viral envelope with subsequent release of the nucleocapsid. 
Proposed mechanism of HSV-1 inactivation on QAC-treated surface. The inactivation 
adsorption step and incubated them with a monolayer of 
BSC-1 cell. Plaques resulting from virus infection were 
formed surrounding all the beads tested. The plaques are 
not caused by the bead’s movement as suggested by a con- 
trol experiment using fresh QAC-treated beads without ad- 
sorbed viruses. However, it is possible that only a small 
fraction of the adsorbed viruses remain infectious. 
DISCUSSION 
These results demonstrate the ability of the QAC-treated 
surface to adsorb HSV-1, an enveloped virus, under vari- 
ous processing conditions. Hydrophobic and electrostatic 
interactions are the predominating forces which effect the 
adsorption of microorganisms to a QAC-treated sur- 
face. 3,5,6-8 For enveloped viruses, the hydrophobic interac- 
tion is presumably the major one since nonenveloped 
viruses show much lower affinity for the QAC-treated sur- 
face (unpublished data). The interactive effects of pH, 
ionic strength, and temperature on the virus adsorption are 
currently under study in our laboratory. 
Based on the observation that virus retains its infectivity 
when adsorbed on a QAC-treated surface together with the 
results from infectivity and radioactivity assays as well as 
the sedimentation analysis, we were able to derive the fol- 
lowing mechanism of inactivation of HSV-1 on the QAC- 
treated surface (Fig. 7). The mechanistic study indicates 
that HSV-1 was inactivated by the QAC-treated surface by 
virtue of the disruption of the viral envelope. This damage 
leads to an irreversible loss of infectivity. None of the evi- 
dence indicates that the released nucleocapsids are further 
disrupted. The virions of HSV-1 are readily adsorbed by 
the QAC-treated surface due to strong hydrophobic and 
other interactions. For the adsorbed virions, the part of en- 
velope that is not in contact with the QAC-treated surface 
is still intact. The nucleocapsid can penetrate into a host 
cell by fusing the intact part of the envelope with the cell 
plasma membrane. The viral envelopes are disrupted when 
the elution is employed and hence only the nucleocapsids 
are released. The nucleocapsid shows a much lower affin- 
ity for the QAC-treated surface. 
The QAC-treated bead made of dried alginate and mag- 
netite used in this study is nonporous. To remove the viral 
contaminants from a protein solution, adsorbents of a non- 
porous nature are preferred in order to eliminate non- 
specific adsorptions of desired proteins onto an intraporous 
surface. 
Despite the fact that the diffusion coefficient of BSA is 
one order of magnitude higher than that of HSV-1, the ad- 
sorption rate of HSV-1 onto the QAC-treated surface is 
greater than that of the BSA. This result indicates that sur- 
face reaction, instead of diffusion, is the controlling step 
of the binding process. HSV-I can readily bind to the 
QAC-treated surface simply because the viral envelope is 
hydrophobic in nature. The kinetic study indicates that 
HSV- 1 was adsorbedhactivated rapidly in the first hour 
following approximately a first-order reaction kinetics with 
respect to the remaining virus concentration in the solu- 
tion. The leveling off of titer reduction is probably due to 
the effect of steric hindrance from previously adsorbed 
viruses and proteins. It has been shown that the residual 
virus titer can be completely eliminated by adding addi- 
tional fresh beads to the suspension. 
The significant reduction of virus adsorption capacity in 
solutions with high BSA concentration (more than 1%) re- 
flects the difficulty involved in the use of the QAC-treated 
beads to remove viruses from solutions with high protein 
contents such as plasma and serum. In this case, the use of 
affinity adsorbents based on specific interactions such as 
antibodies or cellular receptors appears to be more appro- 
priate. Even so, QAC-treated beads certainly can find wide 
applications in treating blood products that have low pro- 
tein content in solution, such as packed red blood cell and 
platelet concentrate. In order to avoid the possible damage 
caused by direct contact, however, a porous membrane 
barrier that allows free passage of viruses should be used 
to exclude the entry of cells. 
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